Arthrex Denied 2nd Shot at Estoppel Challenge By Federal Circuit

The full Federal Circuit has refused to reconsider a panel’s decision upholding a Patent Trial and Appeal Board judgment against suture anchor maker Arthrex Inc. that triggered patent owner estoppel, blocking the company from obtaining future patents on those products, according to a short ruling Monday. Read more in Law360. This decision was also featured in Law360’s “4 Recent Fed. Circ. Rulings IP Attys Need To Know.”